Perceptive Advisors
Perceptive Advisors
Investing in transformative life sciences and healthcare innovations for a healthier future.
About
Investing in transformative life sciences and healthcare innovations for a healthier future. Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.
Key facts
- Website
- perceptivelife.com
- Type
- Hedge Fund
- Headquarters
- New York, United States
- Funds raised
- $9.5B
- Portfolio companies
- 62
- Stages
- Series ESeries F
- Cheque size
- $50M to $250M
- Sector focus
- HealthcareUltrasoundTherapy
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 1 Jun 2026 | Moderna | Funding Round | $50M |
| 17 Mar 2026 | Imperative Care | Series E | $100M |
| 6 Mar 2026 | CRISPR Therapeutics | Series B | $140M |
| 1 Dec 2025 | Moderna | Grant | $54M |
| 1 Nov 2025 | Moderna | Post-IPO Debt | $600M |
| 1 Jul 2024 | Moderna | Grant | $176M |
| 18 Jun 2024 | Insightec | Series F | $150M |
| 2 Apr 2024 | Neurosterix | Series A | $63M |
| 1 Mar 2024 | Moderna | Post-IPO Equity | $750M |
| 13 Feb 2024 | CRISPR Therapeutics | Post IPO | $280M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Write the first review
Frequently asked
What companies has Perceptive Advisors invested in?
Perceptive Advisors has invested in Moderna, Imperative Care, CRISPR Therapeutics, Insightec, Neurosterix and 57 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Perceptive Advisors:
